Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3733037010 | Isoniazid and pyrazinamide and rifampicin only product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3733038017 | Isoniazid and pyrazinamide and rifampin only product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3733039013 | Product containing only isoniazid and pyrazinamide and rifampicin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Isoniazid and pyrazinamide and rifampicin only product | Is a | Medicinal product (product) | true | Inferred relationship | Some | ||
| Isoniazid and pyrazinamide and rifampicin only product | Has active ingredient | Pyrazinamide (substance) | true | Inferred relationship | Some | 1 | |
| Isoniazid and pyrazinamide and rifampicin only product | Has active ingredient | Rifampicin | true | Inferred relationship | Some | 2 | |
| Isoniazid and pyrazinamide and rifampicin only product | Has active ingredient | Isoniazid (substance) | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Isoniazid and pyrazinamide and rifampicin only product | Inferred relationship | Some |
Reference Sets